Literature DB >> 7133054

Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma.

J J Yunis, M M Oken, M E Kaplan, K M Ensrud, R R Howe, A Theologides.   

Abstract

Using a new high-resolution technique for chromosomal analysis, we have successfully studied biopsy specimens of lymph nodes from 42 of 44 patients with non-Hodgkin's lymphoma and have categorized them using the new international histologic formulation and immunologic markers. Abnormalities of the clonal chromosomes were detected in all 42 patients. Three recurrent chromosomal aberrations were found to correlate with certain histologic types: a translocation between chromosomes 18 and 14 in 16 of 19 patients with follicular lymphomas (small cleaved cell, mixed cell, and large cell); a translocation between chromosomes 8 and 14 in 5 of 6 patients with small noncleaved-cell (non-Burkitt's) or large-cell immunoblastic lymphoma; and a trisomy 12 in 4 of 11 patients with small-cell lymphocytic lymphoma. Our findings suggest that characteristic chromosomal defects occur in certain lymphoma subtypes and that high-resolution chromosomal analysis promises to become an important tool in improving our basic understanding of lymphoid cancers.

Entities:  

Mesh:

Year:  1982        PMID: 7133054     DOI: 10.1056/NEJM198211113072002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  77 in total

Review 1.  Detection of BCL2 rearrangements in follicular lymphoma.

Authors:  Jon C Aster; Janina A Longtine
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

2.  Quantitative assessment of disease involvement by follicular lymphoma using real-time polymerase chain reaction measurement of t(14;18)-carrying cells.

Authors:  Woo-In Lee; Fernando Cabanillas; Ming-Sheng Lee
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

Review 3.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

4.  The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.

Authors:  E Athan; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.

Authors:  Janice M Spence; Paul G Rothberg; Nancy Wang; W Richard Burack
Journal:  J Mol Diagn       Date:  2011-05       Impact factor: 5.568

6.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

7.  Microarray analysis of B-cell lymphoma cell lines with the t(14;18).

Authors:  Ryan S Robetorye; Sandra D Bohling; John W Morgan; G Chris Fillmore; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2002-08       Impact factor: 5.568

8.  The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus.

Authors:  J Erikson; J Finan; Y Tsujimoto; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

Authors:  M L Cleary; J Sklar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Assignment of the gene for methylthioadenosine phosphorylase to human chromosome 9 by mouse-human somatic cell hybridization.

Authors:  C J Carrera; R L Eddy; T B Shows; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.